Properties (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
chemical compound
|
| gptkbp:analyzes |
investigational new drug
|
| gptkbp:application |
used in cancer research
|
| gptkbp:chemicalFormula |
stable under normal conditions
urea derivatives high stability C20H24N2O2S reacts with specific enzymes |
| gptkbp:clinicalTrials |
ongoing
Phase I trials potential use in therapies |
| gptkbp:collaborations |
pharmaceutical companies
international research teams |
| gptkbp:compatibleWith |
moderate
anti-tumor activity |
| gptkbp:competitors |
oncology drugs market
|
| gptkbp:composedOf |
multi-step organic synthesis
|
| gptkbp:dissolved |
soluble in DMSO
|
| gptkbp:firstClaim |
expanding research to other cancers
|
| gptkbp:historicalResearch |
partnerships with biotech firms
exploring new formulations |
| https://www.w3.org/2000/01/rdf-schema#label |
LFA 130
|
| gptkbp:isATypeOf |
123456-78-9
|
| gptkbp:market |
high demand for cancer treatments
|
| gptkbp:marketSegment |
not yet marketed
|
| gptkbp:origin |
N-(4-(4-(dimethylamino)phenyl)-6-methyl-2-pyrimidinyl)-N'-methylurea
|
| gptkbp:patentNumber |
US1234567
|
| gptkbp:patentStatus |
patented
|
| gptkbp:productionCompany |
preclinical
|
| gptkbp:regulatoryCompliance |
not_approved_by_FDA
|
| gptkbp:relatedTo |
LFA-1
|
| gptkbp:releaseYear |
2000
|
| gptkbp:research |
grants from government agencies
|
| gptkbp:research_areas |
oncology
|
| gptkbp:researchAndDevelopment |
promising results in early studies
|
| gptkbp:researchField |
pharmaceutical chemistry
|
| gptkbp:researchFocus |
targeting specific cancer types
|
| gptkbp:researchInterest |
academic institutions
various universities compliance with ethical standards multiple peer-reviewed articles high development costs |
| gptkbp:route |
oral
|
| gptkbp:safetyFeatures |
under investigation
limited data available |
| gptkbp:sideEffect |
potential toxicity
|
| gptkbp:storage |
cool, dry place
|
| gptkbp:targets |
lung cancer
breast cancer leukemia inhibitor of certain kinases |
| gptkbp:triggerType |
inhibits cell proliferation
|
| gptkbp:weight |
344.48 g/mol
|